Title: “PulseRider Aneurysm Neck Reconstruction Device (ANRD)”Study Sponsor: CerenovusPrincipal Investigator: Matthew Lawson, MDStudy Synopsis: The PulseRider is authorized by the Federal Law for use with embolic coils for the treatment of un-ruptured, wide-neck, intracranial aneurysms with neck widths≥ 4 mm or dome to neck ration < 2 originating on or near a vessel bifurcation of the basilar tip or carotid terminus with at least a portion of the aneurysm neck overlapping the lumen of the parent artery.The PulseRider have been approved by the Food and Drug Administration (FDA) with a Humanitarian Use Device (HUD) designation. This designation is recognition that the device has a limited patient population of fewer than 8,000 individuals in the United States per year.Study Status: ImplantingFor more information, contact Lutheria Hollis, CCRC at (850) 201-2350